Spaces are limited, please do book early to avoid disappointment.
at any stage of the journey, looking to confidently answer viva questions on unfamiliar or diverse products
supporting trainee QPs, seeking to strengthen application success
wanting to broaden their knowledge and CPD in a shifting manufacturing environment
whose organisations are expanding into new formulation types
The QP conference is a full-day event featuring a series of invited talks, panel sessions, interactive workshops and networking opportunities.
| Time | Item |
| 08:45 | Registration and Coffee |
| 09:15 | Welcome and Introduction to RSSL Emily Ness |
| 09:30 | Role and Duties of a QP in a Diverse and Changing Manufacturing Environment Peter Deegan |
| 09:50 | Investigational Medicinal Products (IMP) Clinical Supply Pam Turner |
| 10:30 | Specials Manufacture Mike Hadabe |
| 11:10 | Coffee and Networking |
| 11:30 | The Progression and Pitfalls of AI in Pharma Martin Lush |
| 12:15 | Inhalation Devices Steve Nolan |
| 13:00 | Lunch and Networking |
| 14:00 | Radiopharmaceuticals manufacturing and release challenges Margaret Cooper |
| 14:45 | Decentralised Manufacturing Model Rebecca Rutter and Ben Broadbent |
| 15:20 | Coffee and Networking |
| 15:40 | Regulatory Update MHRA Speaker TBC |
| 16:20 | Panel discussion |
| 16:40 | Closing remarks and Q&A |
| 16:45 | Final networking |
| 17:00 | End of conference |
Peter is an experienced Pharmaceutical QA professional, with over 30 years GMP, ISO 9001 Quality Systems, audit and training experience.
A Chemistry Graduate, Peter started his career in QC laboratories for a small generics company, before joining ICI (now AstraZeneca) in 1992, where he held QA positions and obtained his Qualified Person status in 1995. He subsequently led a global training organisation for several years, worked in R&D QA and Regulatory Affairs and became Quality Lead for major outsourcing programmes to India and Japan. Peter has experience across a wide range of dosage forms and has a specialism in Pharmaceutical Quality Systems.
Peter established his own consultancy in October 2015, after 23 years with AstraZeneca. He is an active, highly experienced international auditor and has ISO 9001 Pharmaceutical Lead Auditor status. Peter was keynote speaker at the 2015 IRCA Japan symposium on how Pharma has incorporated ISO 9001 into its modern Quality Systems.
Rebecca has more than 25 years' experience in the pharmaceutical industry focussing on IMPs in clinical trials, ATMPs and the transfer of products into commercial production.
She is a C suite capable pharmaceutical quality professional specialising in setting up and running greenfield manufacturing facilities, systems, processes, supply chain and achieving strategic business milestones.
Rebecca’s success stems from her unique combined expertise in both direct manufacturing operations and GMP quality regulatory compliance. This translates to proven achievements (three greenfield sites set up and two decommissioned) seeing the bigger picture to identify and mitigate risks.
With a broad spectrum of auditing complex global supply chains and developing Quality Management and Risk Management Systems, Rebeccahelps organisations as evolve and improve.
Steve is a highly experienced Pharmaceutical Quality professional with over 20 years in GMP-regulated environments, spanning Quality Assurance, Quality Control, and Qualified Person responsibilities. He has held senior leadership roles including Head of Quality and Quality Director, as well as operating as a consultant across a wide range of pharmaceutical organisations. Steve specialises in the design, implementation, and continuous improvement of Pharmaceutical Quality Systems across research, clinical, and commercial manufacturing environments.
He has extensive experience across diverse dosage forms—including sterile and aseptic products, biologics, inhalation therapies, radiopharmaceuticals, and solid dose forms—and has a strong track record of engaging with global regulatory authorities, leading inspections, and delivering successful remediation programmes. As an eligible Qualified Person, Steve brings deep expertise in product release, supply chain oversight, and compliance with EU directives.
Steve is also an accomplished auditor and advisor, having assessed numerous organisations across the pharmaceutical supply chain against GMP, GCP, GLP, and ISO standards.
Qualified Person Bespak Pharmaceuticals
Ben is a Pharmacist with a postgraduate diploma in supply chain and logistics management and is eligible to act as a UK QP under the permanent provisions.
Ben has spent his career working for large pharmaceutical companies in the north west of England across packaging, liquids, tablets, aseptic manufacture and inhalation devices for both commercial and IMP licence holders.
Ben enjoys the challenges of fast paced manufacturing environments and the quality decisions required to support patient health.
Mike is a Pharmacist, Qualified Person and Head of Quality at Eramol (UK) Ltd and Eramol Ltd (IE), where he oversees Quality operations supporting clinical supply, IMP manufacture, packaging, testing and batch certification and release activities.
His background spans NHS and contract manufacturing environments, with experience across sterile and non-sterile manufacturing, GMP compliance, quality systems and regulatory inspection readiness.
Mike has particular experience in the manufacture and supply of unlicensed medicines and Specials, including the practical quality and regulatory considerations associated with special clinical need, MS licence activities, importation, and the interface between commercial, clinical and unlicensed medicinal products.
Maggie Cooper has worked as a radiopharmacist for more than 25 years. She has spent her career working both for the NHS and academia being head of radiopharmacy at the Royal Free Hospital, St. Bartholomew's Hospital and the Royal Liverpool Hospital and also carrying out translational research in radiopharmacy at King's College London.
Maggie currently heads up the Positron Emission Radiopharmaceutical Laboratory at King's College London as the PET chemistry operations manager.
Martin is an EU Qualified Person under the permanent provisions, with more than 44 years of global experience spanning microbiology, pharma manufacturing, aseptic operations, QA, supply chain, consulting and executive leadership. His career has taken him from the NHS laboratory and manufacturing shop floor to Plant Manager, senior QP and Global Vice-President roles, working across vaccines, biologics, sterile injectables and clinical research. Martin now occupies a distinctive position at the intersection of established QP practice and practical AI adoption: he helped develop an early QP chatbot prototype and advises organisations on using AI to simplify QMS processes, strengthen governance and oversight, improve decision-making and augment (not replace) professional judgement. His focus is uncompromisingly practical: translating AI’s potential into controlled, explainable and compliant applications that QPs can trust.
